Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: A comparative binding study.

Biochemistry

Volumn 49, Issue 27, 2010, Pages 5671-5682

  Gomes, Michelle M ^a,e   Suzuki, Hitoshi ^b,d   Brooks, Monica T ^a   Tomana, Milan ^c   Moldoveanu, Zina ^b   Mestecky, Jiri ^b,c   Julian, Bruce A ^b,c   Novak, Jan ^b   Herr, Andrew B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Department of Microbiology ^*  (United States)

^c University of Alabama at Birmingham   (United States)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING STUDIES; CELL LINES; DIAGNOSTIC TOOLS; GLYCOPEPTIDES; GLYCOSYLATED; HEALTHY CONTROLS; IMMUNE COMPLEX; INFLAMMATORY RESPONSE; KIDNEY DISEASE; LECTIN RECOGNITION; MESANGIAL CELLS; NEPHROPATHY; O-GLYCANS; PERIPHERAL BLOOD; SURFACE PLASMON RESONANCE SPECTROSCOPY;

ANTIGENS; BINDING ENERGY; BINDING SITES; BIOCHEMISTRY; BLOOD; CELL CULTURE; DIAGNOSTIC PRODUCTS; SURFACE PLASMON RESONANCE;

COMPLEXATION;

AGGLUTININ; GALACTOSE; GLYCAN DERIVATIVE; GLYCOPEPTIDE; IMMUNOGLOBULIN A1; LECTIN; N ACETYLGALACTOSAMINE; PARAPROTEIN; ANTI IGG; ANTI-IGG; ANTIIDIOTYPIC ANTIBODY; EPITOPE; HELIX LECTIN; IMMUNOGLOBULIN A; POLYSACCHARIDE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; HELIX ASPERSA; HELIX POMATIA; HINGE REGION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; BLOOD; CHEMISTRY; GLYCOSYLATION; IMMUNOLOGY; KIDNEY; MESANGIUM; METABOLISM; PATHOLOGY; SNAIL;

GASTROPODA; HELIX ASPERSA; HELIX POMATIA;

ACETYLGALACTOSAMINE; AGGLUTININS; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES; EPITOPES; GALACTOSE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; KIDNEY; LECTINS; MYELOMA PROTEINS; POLYSACCHARIDES; SNAILS;

EID: 77954692713     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi9019498     Document Type: Article

References (64)

1. Basset, C., Durand, V., Jamin, C., Clement, J., Pennec, Y., Youinou, P., Dueymes, M., and Roitt, I. M. (2000) Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjögren's syndrome. Scand. J. Immunol. 51, 300-306.
2. Lau, K. K., Wyatt, R. J., Moldoveanu, Z., Tomana, M., Julian, B. A., Hogg, R. J., Lee, J. Y., Huang, W. Q., Mestecky, J., and Novak, J. (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr. Nephrol. 22, 2067-2072.
3. Moldoveanu, Z., Wyatt, R. J., Lee, J. Y., Tomana, M., Julian, B. A., Mestecky, J., Huang, W. Q., Anreddy, S. R., Hall, S., Hastings, M. C., Lau, K. K., Cook, W. J., and Novak, J. (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 71, 1148-1154.
4. Saulsbury, F. T. (1997) Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J. Rheumatol. 24, 2246-2249.
5. Mestecky, J., Tomana, M., Crowley-Nowick, P. A., Moldoveanu, Z., Julian, B. A., and Jackson, S. (1993) Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 104, 172-182.
6. Allen, A. C., Harper, S. J., and Feehally, J. (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 100, 470-474.
7. Tomana, M., Matousovic, K., Julian, B. A., Radl, J., Konecny, K., and Mestecky, J. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52, 509-516.
8. Tomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., and Mestecky, J. (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73-81.
9. Suzuki, H., Moldoveanu, Z., Hall, S., Brown, R., Vu, H. L., Novak, L., Julian, B. A., Tomana, M., Wyatt, R. J., Edberg, J. C., Alarcon, G. S., Kimberly, R. P., Tomino, Y., Mestecky, J., and Novak, J. (2008) IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J. Clin. Invest. 118, 629-639.
10. Zickerman, A. M., Allen, A. C., Talwar, V., Olczak, S. A., Brownlee, A., Holland, M., Furness, P. N., Brunskill, N. J., and Feehally, J. (2000) IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am. J. Kidney Dis. 36, E19.
11. Allen, A. C., Willis, F. R., Beattie, T. J., and Feehally, J. (1998) Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol., Dial., Transplant. 13, 930-934.
12. Lasseur, C., Allen, A. C., Deminiere, C., Aparicio, M., Feehally, J., and Combe, C. (1997) Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. Am. J. Kidney Dis. 29, 285-287.
13. Baenziger, J., and Kornfeld, S. (1974) Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide units. J. Biol. Chem. 249, 7260-7269.
14. Baenziger, J., and Kornfeld, S. (1974) Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J. Biol. Chem. 249, 7270-7281.
15. Tomana, M., Niedermeier, W., Mestecky, J., and Skvaril, F. (1976) The differences in carbohydrate composition between the subclasses of IgA immunoglobulins. Immunochemistry 13, 325-328.
16. Torano, A., Tsuzukida, Y., Liu, Y. S., and Putnam, F. W. (1977) Location and structural significance of the oligosaccharides in human Ig-A1 and IgA2 immunoglobulins. Proc. Natl. Acad. Sci. U.S.A. 74, 2301-2305.
17. Liu, Y.-S. V., Low, T. L. K., Infante, A., and Putnam, F. W. (1976) Complete covalent structure of a human IgA1 immunoglobulin. Science 193, 1017-1019.
18. Gomes, M. M., Wall, S. B., Takahashi, K., Novak, J., Renfrow, M. B., and Herr, A. B. (2008) Analysis of IgA1 N-glycosylation and its contribution to FcRRI binding. Biochemistry 47, 11285-11299.
19. Frangione, B., and Wolfenstein-Todel, C. (1972) Partial duplication in the "hinge" region of IgA 1 myeloma proteins. Proc. Natl. Acad. Sci. U.S.A. 69, 3673-3676.
20. Field, M. C., Dwek, R. A., Edge, C. J., and Rademacher, T. W. (1989) O-linked oligosaccharides from human serum immunoglobulin A1. Biochem. Soc. Trans. 17, 1034-1035.
21. Iwase, H., Tanaka, A., Hiki, Y., Kokubo, T., Ishii-Karakasa, I., Kobayashi, Y., and Hotta, K. (1996) Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide. J. Biochem. 120, 393-397.
22. Mattu, T. S., Pleass, R. J., Willis, A. C., Kilian, M., Wormald, M. R., Lellouch, A. C., Rudd, P. M., Woof, J. M., and Dwek, R. A. (1998) The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on FcR receptor interactions. J. Biol. Chem. 273, 2260-2272.
23. Novak, J., Tomana, M., Kilian, M., Coward, L., Kulhavy, R., Barnes, S., and Mestecky, J. (2000) Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol. Immunol. 37, 1047-1056.
24. Renfrow, M. B., Cooper, H. J., Tomana, M., Kulhavy, R., Hiki, Y., Toma, K.,Emmett, M. R., Mestecky, J., Marshall, A. G., and Novak, J. (2005) Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J. Biol. Chem. 280, 19136-19145.
25. Tarelli, E., Smith, A. C., Hendry, B. M., Challacombe, S. J., and Pouria, S. (2004) Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr. Res. 339, 2329-2335.
26. Renfrow, M. B., Mackay, C. L., Chalmers, M. J., Julian, B. A., Mestecky, J., Kilian, M., Poulsen, K., Emmett, M. R., Marshall, A. G., and Novak, J. (2007) Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: Implications for IgA nephropathy. Anal. Bioanal. Chem. 389, 1397-1407.
27. Field, M. C., Amatayakul-Chantler, S., Rademacher, T. W., Rudd, P. M., and Dwek, R. A. (1994) Structural analysis of the N-glycans from human immunoglobulin A1: Comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem. J. 299 (Part 1), 261-275.
28. Allen, A. C., Bailey, E. M., Brenchley, P. E., Buck, K. S., Barratt, J., and Feehally, J. (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int. 60, 969-973.
29. Hiki, Y., Horii, A., Iwase, H., Tanaka, A., Toda, Y., Hotta, K., and Kobayashi, Y. (1995) O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. Contrib. Nephrol. 111, 73-84.
30. Novak, J., Julian, B. A., Tomana, M., and Mestecky, J. (2001) Progress in molecular and genetic studies of IgA nephropathy. J. Clin. Immunol. 21, 310-327.
31. Julian, B. A., and Novak, J. (2004) IgA nephropathy: An update. Curr. Opin. Nephrol. Hypertens. 13, 171-179.
32. Smith, A. C., and Feehally, J. (2003) New insights into the pathogenesis of IgA nephropathy. Pathogenesis of IgA nephropathy. Springer Semin. Immunopathol. 24, 477-493.
33. Suzuki, H., Moldoveanu, Z., Hall, S., Brown, R., Julian, B. A., Wyatt, R. J., Tomana, M., Tomino, Y., Novak, J., and Mestecky, J. (2007) IgA nephropathy: Characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib. Nephrol. 157, 129-133.
34. Kokubo, T., Hiki, Y., Iwase, H., Horii, A., Tanaka, A., Nishikido, J., Hotta, K., and Kobayashi, Y. (1997) Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J. Am. Soc. Nephrol. 8, 915-919.
35. Mestecky, J., Tomana, M., Moldoveanu, Z., Julian, B. A., Suzuki, H., Matousovic, K., Renfrow, M. B., Novak, L., Wyatt, R. J., and Novak, J. (2008) Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Pressure Res. 31, 29-37.
36. Yan, Y., Xu, L. X., Zhang, J. J., Zhang, Y., and Zhao, M. H. (2006) Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin. Exp. Immunol. 144, 17-24.
37. Suzuki, H., Fan, R., Zhang, Z., Brown, R., Hall, S., Julian, B. A., Chatham, W. W., Suzuki, Y., Wyatt, R. J., Moldoveanu, Z., Lee, J. Y., Robinson, J., Tomana, M., Tomino, Y., Mestecky, J., and Novak, J. (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest. 119, 1668-1677.
38. Hiemstra, P. S., Biewenga, J., Gorter, A., Stuurman, M. E., Faber, A., van Es, L. A., and Daha, M. R. (1988) Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Mol. Immunol. 25, 527-533.
39. Zhang, W., and Lachmann, P. J. (1994) Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology 81, 137-141.
40. Roos, A., Rastaldi, M. P., Calvaresi, N., Oortwijn, B. D., Schlagwein, N., van Gijlswijk-Janssen, D. J., Stahl, G. L., Matsushita, M., Fujita, T., van Kooten, C., and Daha, M. R. (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J. Am. Soc. Nephrol. 17, 1724-1734.
41. Roos, A., Bouwman, L. H., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Stahl, G. L., and Daha, M. R. (2001) Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167, 2861-2868.
42. Mody, R., Joshi, S., and Chaney, W. (1995) Use of lectins as diagnostic and therapeutic tools for cancer. J. Pharmacol. Toxicol. Methods 33, 1-10.
43. Brooks, S. A. (2000) The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol. Histopathol. 15, 143-158.
44. Tomana, M. (1996) in Glycoproteins and Disease (Schachter, H., Ed.) pp 291-298, Elsevier, New York.
45. Mackiewicz, A., and Mackiewicz, K. (1995) Glycoforms of serum R1-acid glycoprotein as markers of inflammation and cancer. Glycoconjugate J. 12, 241-247.
46. Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., and Sim, R. B. (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannosebinding protein. Nat. Med. 1, 237-243.
47. Ezaki, T., Baluk, P., Thurston, G., La Barbara, A., Woo, C., and McDonald, D. M. (2001) Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol. 158, 2043-2055.
48. Moore, J. S., Kulhavy, R., Tomana, M., Moldoveanu, Z., Suzuki, H., Brown, R., Hall, S., Kilian, M., Poulsen, K., Mestecky, J., Julian, B. A., and Novak, J. (2007) Reactivities of N-acetylgalactosaminespecific lectins with human IgA1 proteins. Mol. Immunol. 44, 2598-2604.
49. Moore, J. S., Wu, X., Kulhavy, R., Tomana, M., Novak, J., Moldoveanu, Z., Brown, R., Goepfert, P. A., and Mestecky, J. (2005) Increased levels of galactose-deficient IgG in sera of HIV-1- infected individuals. AIDS 19, 381-389.
50. Matousovic,K.,Novak, J.,Yanagihara, T., Tomana,M.,Moldoveanu, Z., Kulhavy, R., Julian, B. A., Konecny, K., and Mestecky, J. (2006) IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol., Dial., Transplant. 21, 2478-2484.
51. Sanchez, J. F., Lescar, J., Chazalet, V., Audfray, A., Gagnon, J., Alvarez, R., Breton, C., Imberty, A., and Mitchell, E. P. (2006) Biochemical and structural analysis of Helix pomatia agglutinin. A hexameric lectin with a novel fold. J. Biol. Chem. 281, 20171-20180.
52. Novak, J., Moldoveanu, Z., Renfrow, M. B., Yanagihara, T., Suzuki, H.,Raska,M., Hall, S., Brown,R.,Huang,W.Q., Goepfert,A., Kilian, M., Poulsen,K.,Tomana,M.,Wyatt,R. J., Julian, B.A., andMestecky, J. (2007) IgA nephropathy and Henoch-Schoenlein purpura nephritis: Aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib. Nephrol. 157, 134-138.
53. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78, 1606-1619.
54. Laue, T. M., Shah, B. D., Ridgeway, T. M., and Pelletier, S. M. (1992) in Analytical ultracentrifugation in biochemistry and polymer science (Harding, S. E., Rowe, A. J., and Horton, J. C., Eds.) pp 90-125, Royal Society of Chemistry, London.
55. Herr, A. B., White, C. L., Milburn, C., Wu, C., and Bjorkman, P. J. (2003) Bivalent binding of IgA1 to FcRRI suggests a mechanism for cytokine activation of IgA phagocytosis. J. Mol. Biol. 327, 645-657.
56. Herr, A. B., Ornitz, D. M., Sasisekharan, R., Venkataraman, G., and Waksman, G. (1997) Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes. J. Biol. Chem. 272, 16382-16389.
57. Andre, P. M., Le Pogamp, P., and Chevet, D. (1990) Impairment of jacalin binding to serum IgA in IgA nephropathy. J. Clin. Lab. Anal. 4, 115-119.
58. Hiki, Y., Odani, H., Takahashi, M., Yasuda, Y., Nishimoto, A., Iwase, H., Shinzato, T., Kobayashi, Y., and Maeda, K. (2001) Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59, 1077-1085.
59. Lee, R. T., and Lee, Y. C. (2000) Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconjugate J. 17, 543-551.
60. Tachibana, K., Nakamura, S., Wang, H., Iwasaki, H., Maebara, K., Cheng, L., Hirabayashi, J., and Narimatsu, H. (2006) Elucidation of binding specificity of Jacalin toward O-glycosylated peptides: Quantitative analysis by frontal affinity chromatography. Glycobiology 16, 46-53.
61. Allen, A. C., Bailey, E. M., Barratt, J., Buck, K. S., and Feehally, J. (1999) Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore- assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 10, 1763-1771.
62. Hiki, Y., Tanaka, A., Kokubo, T., Iwase, H., Nishikido, J., Hotta, K., and Kobayashi, Y. (1998) Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization timeof- flight mass spectrometry. J. Am. Soc. Nephrol. 9, 577-582.
63. Shimozato, S., Hiki, Y., Odani, H., Takahashi, K., Yamamoto, K., and Sugiyama, S. (2008) Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol., Dial., Transplant. 23, 1931-1939.
64. Boehm, M. K., Woof, J. M., Kerr, M. A., and Perkins, S. J. (1999) The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: A study by X-ray and neutron solution scattering and homology modelling. J. Mol. Biol. 286, 1421-1447.